14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler

RxCUI: 1547666
RxNorm name: 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler
Display name: 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler
Full name: 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Arnuity Ellipta	FLUTICASONE FUROATE	GlaxoSmithKline LLC	50f193ee-1691-486d-9370-a664df63695c	2023-10-18	Warnings, Adverse reactions	Exact identifier rxcui: 1547666

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
50f193ee-1691-486d-9370-a664df63695c	14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler	SCD	17	These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 2014	20231018
50f193ee-1691-486d-9370-a664df63695c	fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters	PSN	17	These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 2014	20231018
50f193ee-1691-486d-9370-a664df63695c	fluticasone furoate 200 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT	SY	17	These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 2014	20231018